Difference between revisions of "Team:ETH Zurich/Collaborations"
| Line 7: | Line 7: | ||
<h2><a href="https://2015.igem.org/Team:Amoy#">Amoy</a></h2> | <h2><a href="https://2015.igem.org/Team:Amoy#">Amoy</a></h2> | ||
| − | <p>We collaborated with Amoy team writing in the newsletter. </p> | + | <p>We collaborated with Amoy team writing in the newsletter. We have written about the selection process for iGEM in the <a href="http://issuu.com/amoy-igem/docs/2015newsletterno1?e=17843433/13214508">No1 issue</a> and participated in the questionnaire about the most useful software for us in <a href="http://issuu.com/amoy-igem/docs/2015-newsletter-no.6">No6 issue</a>. |
| + | We also published a description of our project in <a href="http://issuu.com/amoy-igem/docs/2015newsletter-3">No3 issue</a>, an update in <a href="http://issuu.com/amoy-igem/docs/2015newsletterno5">issue No5</a> and abour our human practices in <a href="http://issuu.com/amoy-igem/docs/2015-newsletter-no.7">issue No7</a>. | ||
| + | Finally, we made a short assay about the situation of synthetic biology in Switzerland for the <a href="http://issuu.com/amoy-igem/docs/2015newsletterno4">Special issue</a> and about the ethical dilemmas of editing a human embryo for the <a href="http://issuu.com/amoy-igem/docs/2015newsletterno2?e=17843433/13214519">No2 issue</a>. </p> | ||
<h2><a href="https://2015.igem.org/Team:TU_Darmstadt">Darmstadt</a></h2> | <h2><a href="https://2015.igem.org/Team:TU_Darmstadt">Darmstadt</a></h2> | ||
Revision as of 08:44, 4 September 2015
- Project
- Modeling
- Lab
- Human
Practices - Parts
- About Us
Collaborations
Amoy
We collaborated with Amoy team writing in the newsletter. We have written about the selection process for iGEM in the No1 issue and participated in the questionnaire about the most useful software for us in No6 issue. We also published a description of our project in No3 issue, an update in issue No5 and abour our human practices in issue No7. Finally, we made a short assay about the situation of synthetic biology in Switzerland for the Special issue and about the ethical dilemmas of editing a human embryo for the No2 issue.
Darmstadt
We helped Darmstadt to evaluate their software.
EPFL
EPF Lausanne and ETH Zurich asked together people from the street about their opinions in synthetic biology
Stockholm
We characterized the system of Stockholm regarding the binding of their bacteria to HER2+ breast cancer cells.